Characteristics and treatment patterns of patients with advanced or metastatic non-small cell lung cancer managed with first-line immuno-oncology strategies in Greece: Interim results of a real-world prospective study (IO-HORIZON)

被引：0

作者：

Linardou, H. ^{[1
,2
]}

Charpidou, A. ^{[3
]}

Koumarianou, A. ^{[4
]}

Mountzios, G. ^{[5
,6
]}

Kosmidis, P. A. ^{[7
]}

Christodoulou, C. ^{[8
]}

Mavroudis, D. ^{[9
]}

Christopoulou, A. N. ^{[10
]}

Korantzis, I. ^{[11
]}

Baka, S. ^{[12
]}

Vaslamatzis, M. ^{[13
]}

Athanasiadis, I. ^{[14
]}

Koutras, A. ^{[15
]}

Mauri, D. ^{[16
]}

Kotsakis, A. ^{[17
]}

Ziogas, D. ^{[18
]}

Desiniotis, A. ^{[19
]}

Dimitriadis, I. ^{[19
]}

Syrigos, K. ^{[2
]}

机构：

[1] Metropolitan Hosp, Oncol Dept 4, Athens, Greece

[2] Metropolitan Hosp, Comprehens Clin Trials Ctr, Athens, Greece

[3] Natl & Kapodistrian Univ Athens, Sotiria Hosp Dis Chest, Dept Med 3, Oncol Unit, Athens, Greece

[4] Natl & Kapodistrian Univ Athens, Attikon Univ Hosp, Dept Internal Med 4, Hematol Oncol Unit, Haidari, Greece

[5] Henry Dunant Hosp Ctr, Dept Med Oncol 4, Athens, Greece

[6] Henry Dunant Hosp Ctr, Clin Trials Unit, Athens, Greece

[7] Hygeia Hosp, Dept Med Oncol 2, Maroussi, Greece

[8] Metropolitan Hosp, Dept Med Oncol 2, Athens, Greece

[9] Univ Gen Hosp Herakl, Dept Med Oncol, Iraklion, Greece

[10] St Andrew Hosp, Med Oncol Unit, Patras, Greece

[11] St Lukes Hosp, Dept Oncol, Agios Loukas Clin, Thessaloniki, Greece

[12] Interbalkan European Med Ctr, Dept Oncol, Thessaloniki, Greece

[13] Evangelismos Gen Hosp Athens, Athens, Greece

[14] Mitera Hosp, Dept Med Oncol, Maroussi, Greece

[15] Univ Hosp Patras, Dept Med, Div Oncol, Patras, Greece

[16] Univ Hosp Ioannina, Dept Med Oncol, Ioannina, Greece

[17] Univ Hosp Larissa, Dept Med Oncol, Larisa, Greece

[18] Natl & Kapodistrian Univ Athens, Sch Med, Dept Med 1, Athens, Greece

[19] MSD Greece, Athens, Greece

来源：

JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 04期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

48P

引用

页码：S69 / S70

页数：2

共 50 条

[21] Real-world study of dacomitinib as first-line treatment for patients with EGFR-mutant non-small cell lung cancer
Shin, J. E.
[J]. ANNALS OF ONCOLOGY, 2023, 34 : S1696 - S1697
[22] Real-world study assessing physician rationale for initiating first-line (1L) immuno-oncology (IO) therapy for patients with advanced urothelial cancer (aUC)
Ajmera, M.
Chang, J.
Hitchens, A.
Kearney, M.
Esterberg, E.
Kim, R.
Cappelleri, J.
Devgan, G.
Costa, N.
Candrilli, S.
[J]. ANNALS OF ONCOLOGY, 2021, 32 : S715 - S716
[23] REAL-WORLD TREATMENT PATTERNS FOR PATIENTS WITH METASTATIC HEAD AND NECK SQUAMOUS CELL CARCINOMA (MHNSCC) TREATED WITH IMMUNO-ONCOLOGY (IO) THERAPY
Huang, H.
Shenolikar, R.
Seal, B.
Tse, J.
Burudpakdee, C.
[J]. VALUE IN HEALTH, 2019, 22 : S390 - S390
[24] Real-world immuno-oncology (IO) therapy treatment patterns and outcomes in patients with anaplastic lymphoma kinase positive (ALK1) non-small cell lung cancer (NSCLC) in the United States
Pan, X.
Lin, M. M.
Yin, Y.
Hou, P.
Baumann, P.
Jahanzeb, M.
[J]. ANNALS OF ONCOLOGY, 2019, 30
[25] First-line treatment patterns and outcomes in advanced non-small cell lung cancer in Sweden: a population-based real-world study with focus on immunotherapy
Wagenius, Gunnar
Vikstrom, Anders
Berglund, Anders
Salomonsson, Stina
Bencina, Goran
Hu, Xiaohan
Chirovsky, Diana
Brunnstrom, Hans
[J]. ACTA ONCOLOGICA, 2024, 63 : 198 - 205
[26] Real-world chemotherapy treatment patterns in metastatic non-small cell lung cancer: Are patients undertreated?
Sacher, Adrian G.
Le, Lisa W.
Lau, Anthea
Earle, Craig C.
Leighl, Natasha B.
[J]. CANCER, 2015, 121 (15) : 2562 - 2569
[27] Immunotherapy for the First-Line Treatment of Patients with Metastatic Non-Small Cell Lung Cancer
Martinez, Pablo
Peters, Solange
Stammers, Timothy
Soria, Jean-Charles
[J]. CLINICAL CANCER RESEARCH, 2019, 25 (09) : 2691 - 2698
[28] COST OF CARE IN ADVANCED NON-SMALL CELL LUNG CANCER (ANSCLC) IN THE IMMUNO-ONCOLOGY (10) ERA: A REAL-WORLD ANALYSIS OF EARLY DATA
Radtchenko, J.
Korytowsky, B.
Nwokeji, E.
Tuell, K.
Feinberg, B.
[J]. VALUE IN HEALTH, 2018, 21 : S122 - S123
[29] Gefitinib for the first-line treatment of locally advanced or metastatic non-small cell lung cancer
Brown, T.
Boland, A.
Bagust, A.
Oyee, J.
Hockenhull, J.
Dundar, Y.
Dickson, R.
Ramani, V. S.
Proudlove, C.
[J]. HEALTH TECHNOLOGY ASSESSMENT, 2010, 14 : 71 - 79
[30] Pemetrexed for the first-line treatment of locally advanced or metastatic non-small cell lung cancer
Fleeman, N.
Bagust, A.
McLeod, C.
Greenhalgh, J.
Boland, A.
Dundar, Y.
Dickson, R.
Smith, C. Tudur
Davis, H.
Green, J.
Pearson, M.
[J]. HEALTH TECHNOLOGY ASSESSMENT, 2010, 14 : 47 - 53

← 1 2 3 4 5 →